P34 Outcomes after using vedolizumab in paediatric inflammatory bowel disease in a tertiary centre, over a 3 year period
2017 ◽
Vol 11
(suppl_1)
◽
pp. S297-S297
◽
2016 ◽
Vol 10
(suppl 1)
◽
pp. S496.2-S496
2016 ◽
Vol 10
(suppl 1)
◽
pp. S351.1-S351
2019 ◽
Vol 13
(Supplement_1)
◽
pp. S214-S215
Keyword(s):
2016 ◽
Vol 10
(suppl 1)
◽
pp. S201.3-S202
Keyword(s):